Come up with a name for your new list and we'll add to it:
Adheron Therapeutics was acquired by
Roche Holding on October 09, 2015.
Adheron Therapeutics, formerly Synovex, is a biotechnology company focused on leveraging pioneering technology that disrupts cell adhesion to treat a variety of diseases. The target is Cadherin 11, a …